Ghent University Academic Bibliography

Journal Article
A1
open access

CCR2-and Flt3-dependent inflammatory conventional type 2 dendritic cells are necessary for the induction of adaptive immunity by the human vaccine adjuvant system AS01

Cedric Bosteels (UGent) , Kaat Fierens (UGent) , Sofie De Prijck (UGent) , Justine Van Moorleghem (UGent) , Manon Vanheerswynghels (UGent) , Caroline De Wolf (UGent) , Aurelie Chalon, Catherine Collignon, Hamida Hammad (UGent) , Arnaud M. Didierlaurent, et al.

(2021) FRONTIERS IN IMMUNOLOGY. 11.

Add to list

Journal Article

TAO-kinase 3 governs the terminal differentiation of conventional dendritic cells

Matthias Vanderkerken (UGent) , Bastiaan Maes (UGent) , Lana Vandersarren (UGent) , Wendy Toussaint (UGent) , Kim Deswarte (UGent) , Manon Vanheerswynghels (UGent) , Philippe Pouliot (UGent) , Liesbet Martens (UGent) , Sofie Van Gassen (UGent) , Connie M. Arthur, et al.

(2020) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 117(49). p.31331-31342

Add to list

Metabolic and innate immune cues merge into a specific inflammatory response via the UPR

Denis A Mogilenko, Joel T Haas, Laurent L’homme, Sébastien Fleury, Sandrine Quemener, Matthieu Levavasseur, Coralie Becquart, Julien Wartelle, Alexandra Bogomolova, Laurent Pineau, et al.

(2019) CELL. 177. p.1201-1216

Add to list

Journal Article
A1
open access

Vaccine strategies to improve anti-cancer cellular immune responses

Karim Vermaelen (UGent)

(2019) FRONTIERS IN IMMUNOLOGY. 10.

Add to list

An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA loaded dendritic cells for cancer vaccination

Elisabeth Brabants (UGent) , Kelly Heyns (UGent) , S De Smet, Pam Devreker (UGent) , Joline Ingels (UGent) , Nancy De Cabooter (UGent) , Veronique Debacker (UGent) , Melissa Dullaers (UGent) , JP Van Meerbeeck, Bart Vandekerckhove (UGent) , et al.

(2018) CYTOTHERAPY. 20(9). p.1164-1181

Add to list

Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy : restoring the immunogenicity of immunosilent mRNA

Rein Verbeke (UGent) , Ine Lentacker (UGent) , Laura Wayteck (UGent) , Karine Breckpot, Mieke Van Bockstal (UGent) , Benedicte Descamps (UGent) , Christian Vanhove (UGent) , Stefaan De Smedt (UGent) and Heleen Dewitte (UGent)

(2017) JOURNAL OF CONTROLLED RELEASE. 266. p.287-300

Add to list

Journal Article
A1
open access

The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome

Lotte Pyfferoen (UGent) , Elisabeth Brabants (UGent) , Celine Everaert (UGent) , Nancy De Cabooter (UGent) , Kelly Heyns (UGent) , Kim Deswarte (UGent) , Manon Vanheerswynghels (UGent) , Sofie De Prijck (UGent) , Glenn Waegemans, Melissa Dullaers (UGent) , et al.

(2017) ONCOIMMUNOLOGY. 6(1).

Add to list

The ReNAissanCe of mRNA-based cancer therapy

Sandra Van Lint (UGent) , Dries Renmans, Katrijn Broos, Heleen Dewitte (UGent) , Ine Lentacker (UGent) , Carlo Heirman, Karine Breckpot and Kris Thielemans

(2015) EXPERT REVIEW OF VACCINES. 14(2). p.235-251

Add to list

Intratumoral delivery of mRNA : overcoming obstacles for effective immunotherapy

Kevin Van Der Jeught, Sandra Van Lint (UGent) , Kris Thielemans and Karine Breckpot

(2015) ONCOIMMUNOLOGY. 4(5).

Add to list

Mononuclear phagocytes of the intestine, the skin, and the lung

Charlotte Scott (UGent) , Sandrine Henri and Martin Guilliams (UGent)

(2014) IMMUNOLOGICAL REVIEWS. 262(1). p.9-24

Academic Bibliography

CCR2-and Flt3-dependent inflammatory conventional type 2 dendritic cells are necessary for the induction of adaptive immunity by the human vaccine adjuvant system AS01

TAO-kinase 3 governs the terminal differentiation of conventional dendritic cells

Metabolic and innate immune cues merge into a specific inflammatory response via the UPR

Vaccine strategies to improve anti-cancer cellular immune responses

An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA loaded dendritic cells for cancer vaccination

Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy : restoring the immunogenicity of immunosilent mRNA

The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome

The ReNAissanCe of mRNA-based cancer therapy

Intratumoral delivery of mRNA : overcoming obstacles for effective immunotherapy

Mononuclear phagocytes of the intestine, the skin, and the lung

Contents

Support

Contact